CAS
MRNA icon

Coppell Advisory Solutions’s Moderna MRNA Stock Holding History

Coppell Advisory Solutions’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-242
Closed -$28.7K – 1929
2024
Q2 		$28.7K Buy
+242
New +$30.6K ﹤0.01% 647
2023
Q4 		$17K Buy
171
+110
+180% +$9.25K ﹤0.01% 787
2023
Q3 		$11K Sell
61
-27
-31% -$3.01K ﹤0.01% 593
2023
Q2 		$10.7K Buy
+88
New +$11.7K ﹤0.01% 675
2023
Q1 		– Sell
-61
Closed -$11K – 739
2022
Q4 		$11K Buy
+61
New +$9.97K ﹤0.01% 595

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Coppell Advisory Solutions's MRNA Position: Q3 2024 in Review

Coppell Advisory Solutions sold out of Moderna (MRNA) in Q3 2024, closing a stake of 242 shares — an estimated $28.7K sold.

Coppell Advisory Solutions first reported a position in MRNA in Q4 2022 and held it in 5 quarters. The position peaked at $28.7K in Q2 2024. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Coppell Advisory Solutions reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Coppell Advisory Solutions sold 242 Moderna shares in Q3 2024, an estimated $28.7K.
  • Coppell Advisory Solutions first reported a position in Moderna in Q4 2022 and held it in 5 quarters.
  • Coppell Advisory Solutions's Moderna position peaked at $28.7K in Q2 2024.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Coppell Advisory Solutions's 13F filing for Q3 2024, filed 14 Nov 2024.